Autologous GVHD?

Bone Marrow Transplantation

Volumn 49, Issue 11, 2014, Pages 1349-1351

  Otegbeye, F ^a   Gale, R P ^b   Lazarus, H M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Haematology Research Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACUTE GRAFT VERSUS HOST DISEASE; AUTOLOGOUS GRAFT VERSUS HOST DISEASE; AUTOTRANSPLANTATION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; LABORATORY DIAGNOSIS; MEDICAL TERMINOLOGY; MONOZYGOTIC TWINS; NONHUMAN; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; AUTOGRAFT; STEM CELL TRANSPLANTATION;

AUTOGRAFTS; GRAFT VS HOST DISEASE; HUMANS; STEM CELL TRANSPLANTATION;

EID: 84909947490     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.169     Document Type: Review

References (38)

1. Gale RP, Lazarus HM. 'A rose by any other name would smell as sweet', or would it? Bone Marrow Transplant 2013; 48: 881-883.
2. Lorenz E, Uphoff D, Reid TR, Shelton E. Modification of irradiation injury in mice and guinea pigs by bone marrow injection. J Natl Cancer Inst 1951; 12: 197-201.
3. Main JM, Prehn RT. Successful skin homografts after the administration of high dosage X irradiation and homologous bone marrow. J Natl Cancer Inst 1955; 15: 1023-1030.
4. Jones JM, Wilson R, Bealmear PM. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res 1971; 45: 577-580.
5. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974; 52: 401-406.
6. Brandon JA, Jennings CD, Kaplan AM, Bryson JS. Murine syngeneic graft-versushost disease is responsive to broad-spectrum antibiotic therapy. J Immunol 2011; 186: 3726-3734.
7. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-1561.
8. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
9. Deeg HJ, Antin JH. The clinical spectrum of acute graft-versus-host disease. Semin Hematol 2006; 43: 24-31.
10. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
11. Sale GE, Lerner KG, Barker EA, Shulman HM, Thomas ED. The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol 1977; 89: 621-636.
12. Kohler S, Hendrickson MR, Chao NJ, Smoller BR. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. Am J Surg Pathol 1997; 21: 988-996.
13. Horn TD, Redd JV, Karp JE, Beschorner WE, Burke PJ, Hood AF. Cutaneous eruptions of lymphocyte recovery. Arch Dermatol 1989; 125: 1512-1517.
14. Sale GE, Shulman HM, McDonald GB, Thomas ED. Gastrointestinal graft-versushost disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol 1979; 3: 291-299.
15. Paczseny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R et al. A biomarker panel for acute graft-versus-host disease. Blood 2009; 113: 273-278.
16. Pencina MJ, D'Agostino RB, Pencina KM, Janssens CJW, Grrenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 2012; 176: 473-481.
17. Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED. Histopathology of graft-vs-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974; 6: 367-371.
18. Holmberg L, Kikuchi K, Gooley TA, Adams KM, Hockenbery DM, Flowers ME et al. Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. Biol Blood Marrow Transplant 2006; 12: 226-234.
19. LeBoit PE. Subacute radiation dermatitis: a histologic imitator of acute cutaneous graft-versus-host disease. J Am Acad Dermatol 1989; 20: 236-241.
20. Horn TD. Acute cutaneous eruptions after marrow ablation: roses by other names? J Cutan Pathol 1994; 21: 385-392.
21. Fitzpatrick JE. The cutaneous histopathology of chemotherapeutic reactions. J Cutan Pathol 1993; 20: 1-14.
22. Yokel BK, Friedman KJ, Farmer ER, Hood AF. Cutaneous pathology following etoposide therapy. J Cutan Pathol 1987; 14: 326-330.
23. Bolanos-Meade J, Garett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ et al. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biol Blood Marrow Transplant 2007; 13: 1185-1191.
24. Hood AF, Vogelsang GB, Black LP, Farmer ER, Santos GW. Acute graft-vs-host disease: development following autologous and syngeneic bone marrow transplantation. Arch Dermatol 1987; 123: 745-750.
25. Rappeport J, Mihm M, Reinherz E, Lopansri S, Parkman R. Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors. Lancet 1979; 2: 717-720.
26. Drobyski WR, Hari P, Keever-Taylor C, Komorowski R, Grossman W. Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma. Bone Marrow Transplant 2009; 43: 169-177.
27. Lazarus HM, Sommers SR, Arfons LM, Fu P, Ataergin SA, Kaye NM et al. Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts. Biol Blood Marrow Transplant 2011; 17: 970-978.
28. Adams KM, Holmberg LA, Leisenring W, Fefer A, Guthrie KA, Tylee TS et al. Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. Blood 2004; 104: 1894-1897.
29. Cogbill CH, Drobyski WR, Komorowski RA. Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of. 17. cases. Mod Pathol 2011; 24: 117-125.
30. Gluckman E, Devergie A, Sohier J, Saurat JH. Graft-versus-host disease in recipients of syngeneic bone marrow. Lancet 1980; 1: 253-254.
31. Bruder CE, Piotrowski A, Gijsbers AA, Andersson R, Erickson S, Diaz de Stahl T et al. Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 2008; 82: 763-771.
32. Bauer DJ, Hood AF, Horn TD. Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery. Arch Dermatol 1993; 129: 855-858.
33. Li N, Guthrie KA, Storer BE, Martin PJ, Sale GE, Argenyi ZB et al. Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period. Biol Blood Marrow Transplant 2012; 18: 1281-1286.
34. Adams KM, Lambert NC, Heimfeld S, Tylee TS, Pang JM, Erickson TD et al. Male DNA in female donor apheresis and CD 34-enriched products. Blood 2003; 102: 3845-3847.
35. Kline J, Subbiah S, Lazarus HM, van Besien K. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance. Bone Marrow Transplant 2008; 41: 505-513.
36. Hinterberger W, Rowlings PA, Hinterberger-Fischer M, Gibson J, Jacobsen N, Klein JP et al. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med 1997; 126: 116-122.
37. Castaño E, Rodríguez-Peralto JL, López-Ríos F, Gómez C, Zimmermann M, Iglesias Díez L. Keratinocyte dysplasia: an usual finding after transplantation or chemotherapy. J Cutan Pathol 2002; 29: 579-584.
38. Burgdorf WH, Gilmore WA, Ganick RG. Peculiar acral erythema secondary to highdose chemotherapy for acute myelogenous leukemia. Ann Intern Med 1982; 97: 61-62.